MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SP3004b    
Morpholino sequence: GGTCCAAAATGGAGTCTTCATGACT
Find in Genbank
Target name: pnoc
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
GTTTGGCCTACTGGAGCAGTTGAAAAACCCAGAAGCTGAAGATTGGACATATCCACCACACCTCAAGACTGAAAGTGACAGAGAGACCCCTTATCACCGACGGCAGAGAGCCCAGTGTCTGATCTGAAGTTCCTGCCTCATTCCTTTGTTCTGTGAAGAAGTCATGAAGACTCCATTTTGGACCCTGCTGCTCTTATGCTTGTGCGCTTCAAGTCACAGCGACTGCCAAGGGGACTGCTTAACCTGTGGACTCATCCTGCCTGAACACCAAGCTTTTAATACACTGGTGTGTATCCTGGAATGTGAAGCACAGGCGTCTCCGGCACTGACCTGGGATCTGTGTTACCAAGCAGCGGGTTTGAAGCATCTCCCACTGCCCTTGCAGGACGAGGAAACATCAAAGCGCTCGGATGATGAAGCGGAGCCTGTGGCTACAGTCAGCATAGAGAATGACAACGGTGTCGAATACACGGAGGCTTTAGAGCGCTTTCGACACGCTCTGCAGCCTTCAGAAGAGCTGGAGAAACTCACGGCTTCATATGACCCAGACCTCGACCCGCGGACACAGGAAGACCAGGATGATTTAGGAGACGAGAAGAGCGACGACGCAGCCGTAAGCGTGTCCAAACGATTCGGGGGCTTCATGAAAGGTCGTCACGGTTTACGTAAGCTGGTGAGCTCCGGAAGGCCTTTGCAGAAGCGCTACGGAGGCTTCATAGGGATCAGAAAGTCTGCCCGTAAGTGGAACAACCAGAAGCGCGTGAGTCAGCTCCTGCGCCAGTACCTGAGTTTAACGGGCCGGTCAGGTCGCTCGGGTCACATCAACAGCCTCTCCACCAGAATCCGGAGACAGAGCGAGGCGTAGGTGGCTGTTAACACAGGCCACGGTCACTTACCTCATCAGTAACTGTGAACATCTCCATCATGACATGCACCGCGACCCCAGAACTAACGTTAGATGTAAATCTGTGTTTAATCAAAGAAGAGGAATATTTTGTATAGCTGGGTTTTTAATCATTGACATTTCCATGGTGGCGACATCCCCCCCAAAAAAGCATCTGTTAGGACGAATGTTGCTGATGATGAGAACTGATTGTTCATTTATCTGAAACTCCGTCAATTAACCTTTGAAGCATTGTGAATACAAATAA
Gene targeted:
prepronociceptin
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Pigment: (7)
Kidney: (3)
Vasculature: (5)
Eye: (2)
- tail coiled
(14.29%, dose:3ng, p53:4.5ng, days: -)
- iridophores decreased
(10%, dose:4.5ng, p53:6.75ng, days: -)
- tail coiled
(11.76%, dose:4.5ng, p53:6.75ng, days: -)
- eye dysplastic
(10%, dose:6ng, p53:9ng, days: -)
- eye small size
(40%, dose:6ng, p53:9ng, days: -)
- common cardinal vein edematous
(10%, dose:6ng, p53:9ng, days: -)
- iridophores decreased
(30%, dose:6ng, p53:9ng, days: -)
- head dysplastic
(10%, dose:6ng, p53:9ng, days: -)
- head small size
(70%, dose:6ng, p53:9ng, days: -)
- tail coiled
(11.76%, dose:6ng, p53:9ng, days: -)
- tail short length
(14.29%, dose:6ng, p53:9ng, days: -)

Images